Hematology
Megan Kruse, M.D.
Director of Breast Medical Oncology and Co-Leader, Breast Cancer Program
Cleveland, OH
Dr. Megan Kruse, M.D., is a hematologist and medical oncologist specializing in breast cancer, with a particular focus on invasive lobular carcinoma (ILC), triple-negative breast cancer, and HR+/HER2- breast cancer. She serves adult patients, including those with metastatic and treatment-refractory cases, through her leadership of the Comprehensive Lobular Breast Cancer Program at Cleveland Clinic, which features a dedicated ILC clinical care pathway, integrated research initiatives, and philant
15+
Years in Practice
Credentials
Education & Training
- Medical School: Case Western Reserve University School of Medicine (MD, 2011)
- Residency: UPMC Medical Education (Internal Medicine, 2011-2014)
- Fellowship: Cleveland Clinic Foundation (Hematology and Medical Oncology, 2014-2017)
Clinical Focus
Subspecialties
Hematology & Oncology
Conditions & Treatments
LeukemiaLymphomaMultiple MyelomaHematologic Malignancies
Practice Details
Hospital Affiliations
- Akron General Medical Center
- Cleveland Clinic Avon Hospital
- Cleveland Clinic
- Fairview Hospital
- Medina Hospital
Languages
English
Experience
15+ years in practice